In clinical trials of Wegovy, which included a higher dose of injectable semaglutide (2.4 mg), people lost an average of almost 15 percent of their body weight
It helps to reduce the appearance of dark spots and uneven skin tone and leaves the skin feeling hydrated and looking more radiant
Additionally, between November 17, 2025, and March 31, 2026, new Wegovy patients can receive the first two doses (0.25 and 0.5 mg) for $199 per month
There are also more flexible schedules, like alternate-day fasting, to choose from
Our team of defective drug attorneys welcomes a challenge
The Rise of GLP-1 Medications and a New Skin Concern In recent years, prescriptions for semaglutide, tirzepatide, and liraglutide have skyrocketed